- Condition: Essential Hypertension
Interventions: Drug: XOMA 985; Drug: Amlodipine Besylate; Drug: Perindopril Erbumine
Sponsors: XOMA (US) LLC; XOMA (US) LLC
Recruiting - verified March 2012 - Condition: Nocturia
Intervention: Drug: Desmopressin
Sponsors: Ferring Pharmaceuticals; Ferring Pharmaceuticals
Recruiting - verified April 2012 - Condition: Cardiovascular Disease
Interventions: Dietary Supplement: ResA; Dietary Supplement: Resveratrol; Dietary Supplement: Placebo
Sponsors: University of California, Davis; University of California, Davis; Gateway Health Alliance
Not yet recruiting - verified March 2012 - Condition: Argininosuccinate Synthetase Deficient
Intervention: Drug: ADI-PEG 20
Sponsors: Polaris Group; Polaris Group
Recruiting - verified February 2012 - Conditions: Solid Tumors; Prostate Cancer
Intervention: Drug: ADI-PEG 20
Sponsors: Polaris Group; Polaris Group
Recruiting - verified December 2011 - Condition: Heart Transplant
Intervention: Drug: L-arginine
Sponsors: University of Michigan; University of Michigan
Recruiting - verified December 2011 - Conditions: Hypertension; Diabetes
Interventions: Dietary Supplement: L-Arginine; Dietary Supplement: Placebo Supplement
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified April 2012 - Condition: Type I Diabetes Mellitus
Interventions: Dietary Supplement: Glutamine; Dietary Supplement: Placebo
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Thrasher Research Fund
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Simvastatin + L-Arginine + Tetrahydrobiopterin
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified May 2012 - Conditions: Dystrophinopathy; Duchenne Muscular Dystrophy; Becker's Muscular Dystrophy
Intervention: Drug: L-arginine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified January 2012 - Condition: Blood Loss, Surgical
Intervention: Drug: Vasopressin
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Beth Israel Deaconess Medical Center; Northshore Medical Center; Cedars-Sinai Medical Center
Recruiting - verified May 2012 - Condition: Placebo Analgesia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight InfantsCondition: Hypotension
Interventions: Drug: Dopamine; Drug: Arginine Vasopressin
Sponsors: Baylor College of Medicine; Baylor College of Medicine; Thrasher Research Fund
Recruiting - verified June 2011 - Condition: Hepatocellular Carcinoma
Interventions: Drug: ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol); Drug: Placebo
Sponsors: Polaris Group; Polaris Group
Recruiting - verified March 2012 - Condition: Small Cell Lung Cancer
Intervention: Drug: ADI-PEG 20 (Arginine deiminase pegylated)
Sponsors: Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; Memorial Sloan-Kettering Cancer Center; Duke University; Polaris Group
Recruiting - verified April 2012 - Condition: Healthy
Intervention: Drug: Fulvestrant
Sponsors: Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH); AstraZeneca
Recruiting - verified April 2012 - Condition: Autism Spectrum Disorders
Interventions: Drug: Oxytocin; Drug: Vasopressin
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified June 2011 - Conditions: Hemophilia A; Von Willebrand Disease
Intervention: Biological: Neumega (Oprelvekin, Interleukin 11, IL-11)
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified July 2011 - Condition: Intracerebral Hemorrhage
Intervention: Drug: DDAVP injection (desmopressin acetate)
Sponsors: Northwestern University; Northwestern University; Northwestern Memorial Hospital
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: Adalimumab
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: Pre-diabetes; Type 2 Diabetes
Interventions: Drug: Exenatide; Drug: Sitagliptin; Drug: Glimepiride
Sponsors: University of Pennsylvania; University of Pennsylvania; Pennsylvania Department of Health
Recruiting - verified November 2011 - Condition: Blood Pressure
Interventions: Drug: L-citrulline; Drug: Placebo
Sponsors: University of Pittsburgh; University of Pittsburgh; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011 - Condition: Colorectal Cancer
Intervention: Drug: Aspirin
Sponsors: University of California, Irvine; University of California, Irvine
Recruiting - verified March 2012 - Condition: Protein Metabolism
Intervention: Dietary Supplement: Arginine
Sponsors: University of Arkansas; University of Arkansas
Recruiting - verified December 2011 - Condition: Hypertension
Interventions: Drug: Clonidine; Drug: Nitroglycerin transdermal; Drug: Dipyridamole/ Aspirin (Aggrenox); Drug: Desmopressin (DDAVP); Drug: Sildenafil; Drug: Nifedipine; Drug: Hydralazine; Drug: Hydrochlorothiazide; Drug: Placebo; Drug: Bosentan; Drug: Diltiazem; Drug: Eplerenone; Drug: guanfacine; Dietary Supplement: L-arginine; Drug: captopril; Drug: carbidopa; Drug: losartan; Drug: metoprolol tartrate; Drug: nebivolol hydrochloride; Drug: prazosin hydrochloride; Drug: tamsulosin hydrochloride; Other: Head-up tilt.
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012
 |
Arginine Clinical Trials |
